Haemonetics Reports 4th Quarter Fiscal 2015 Revenue of $226 Million and Adjusted EPS of $0.47; Full Year Revenue of $910 Million and Adjusted EPS of $1.85; Provides Fiscal 2016 Guidance
Go back to Haemonetics Reports 4th Quarter Fiscal 2015 Revenue of $226 Million and Adjusted EPS of $0.47; Full Year Revenue of $910 Million and Adjusted EPS of $1.85; Provides Fiscal 2016 Guidance| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 72.53 -1.64 (2.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $74.17 | 52 Week High | $39.41 | |||
| Open | $72.89 | 52 Week Low | $25.98 | |||
| Day High | $74.26 | P/E | 102.15 | |||
| Day Low | $72.45 | EPS | $0.71 | |||
| Volume | 1,171,854 | |||||
